These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10417291)

  • 41. CDKN2A mutation and deletion status in thin and thick primary melanoma.
    Cachia AR; Indsto JO; McLaren KM; Mann GJ; Arends MJ
    Clin Cancer Res; 2000 Sep; 6(9):3511-5. PubMed ID: 10999737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic alterations in melanocytic tumors.
    Takata M; Saida T
    J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CDKN2A mutations in multiple primary melanomas.
    Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
    N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
    Goldstein AM; Struewing JP; Chidambaram A; Fraser MC; Tucker MA
    J Natl Cancer Inst; 2000 Jun; 92(12):1006-10. PubMed ID: 10861313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype.
    Bertram CG; Gaut RM; Barrett JH; Randerson-Moor J; Whitaker L; Turner F; Bataille V; dos Santos Silva I; Swerdlow AJ; Bishop DT; Newton Bishop JA
    J Invest Dermatol; 2004 Feb; 122(2):429-32. PubMed ID: 15009726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Familial multiple naevogene melanomas. Electronmicroscopical findings in pigmented moles of the B-K-mole syndrome (author's transl)].
    Wassilew S; Jänner M; Schaeg G
    Z Hautkr; 1981 Jul; 56(14):931-41. PubMed ID: 7269718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma.
    Ruiz A; Puig S; Lynch M; Castel T; Estivill X
    Int J Cancer; 1998 May; 76(3):312-6. PubMed ID: 9579564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melanocytic nevi in schoolchildren in Queensland.
    Green A; Siskind V; Hansen ME; Hanson L; Leech P
    J Am Acad Dermatol; 1989 Jun; 20(6):1054-60. PubMed ID: 2754055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
    Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
    Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Power of regression and maximum likelihood methods to map QTL from sib-pair and DZ twin data.
    Visscher PM; Hopper JL
    Ann Hum Genet; 2001 Nov; 65(Pt 6):583-601. PubMed ID: 11851988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetics of familial and sporadic melanoma.
    Bataille V
    Clin Exp Dermatol; 2000 Sep; 25(6):464-70. PubMed ID: 11044180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review: Are moles senescent?
    Bennett DC
    Pigment Cell Melanoma Res; 2024 May; 37(3):391-402. PubMed ID: 38361107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome".
    Ipenburg NA; Gruis NA; Bergman W; van Kester MS
    J Am Acad Dermatol; 2016 Oct; 75(4):e157. PubMed ID: 27646763
    [No Abstract]   [Full Text] [Related]  

  • 54. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate.
    Tsao H; Bevona C; Goggins W; Quinn T
    Arch Dermatol; 2003 Mar; 139(3):282-8. PubMed ID: 12622618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant melanoma--a genetic overview.
    Bloethner S; Scherer D; Drechsel M; Hemminki K; Kumar R
    Actas Dermosifiliogr; 2009 Nov; 100 Suppl 1():38-51. PubMed ID: 20096196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma.
    Sini MC; Manca A; Cossu A; Budroni M; Botti G; Ascierto PA; Cremona F; Muggiano A; D'Atri S; Casula M; Baldinu P; Palomba G; Lissia A; Tanda F; Palmieri G
    Br J Dermatol; 2008 Feb; 158(2):243-50. PubMed ID: 18028495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families.
    van der Velden PA; Sandkuijl LA; Bergman W; Hille ET; Frants RR; Gruis NA
    Genome Res; 1999 Jun; 9(6):575-80. PubMed ID: 10400925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.
    Eskandarpour M; Hashemi J; Kanter L; Ringborg U; Platz A; Hansson J
    J Natl Cancer Inst; 2003 Jun; 95(11):790-8. PubMed ID: 12783933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and environmental influences in the development of multiple primary melanoma.
    Burden AD; Newell J; Andrew N; Kavanagh G; Connor JM; MacKie RM
    Arch Dermatol; 1999 Mar; 135(3):261-5. PubMed ID: 10086446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
    van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.